Skip to Content
 

News: Donor supported research

Cancer Center Ambassadors surpass $1 million in grants

Friday, March 15th, 2019

Vanderbilt-Ingram Cancer Center Ambassadors surpassed the $1 million mark with the awarding of the group’s latest research grants.

Cancer fight personal for VICC Ambassadors chair

Saturday, December 1st, 2018

As this year’s chair of the VICC Ambassadors, Ashley Larcinese, is driven by her experiences to see that research is funded at VICC.

Mary Kay Foundation grant to bolster immunotherapy research

Monday, October 22nd, 2018

Charles Caskey, Ph.D., has received a cancer research grant from The Mary Kay Foundation to study how focused ultrasound therapy could be an ideal helper for immunotherapy.

Entertainers’ support strengthens VICC melanoma research efforts

Friday, April 13th, 2018

Henry Paul and Dave Robbins, members of country music group BlackHawk, as well as southern rock band The Outlaws, recently donated $40,000 to Vanderbilt-Ingram Cancer Center (VICC) in support of melanoma research.

Study seeks to boost breast tumor immune response

Thursday, February 8th, 2018

Targeting specific molecules in breast tumors, called methylating agents, can turn up the immune response, potentially making tumors responsive to immunotherapy, suggests a new study published in Nature Communications.

VUMC researchers find a way to ‘starve’ cancer

Thursday, January 18th, 2018

Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital nutrient glutamine.

Liquid biopsies help reveal lung cancer mutations

Thursday, November 2nd, 2017

Cancer investigators led by researchers at Vanderbilt-Ingram Cancer Center have co-developed a liquid biopsy blood-based assay used to identify specific gene mutations associated with the development or relapse of small-cell lung cancer (SCLC)

Chic Awearness event supports VUMC ovarian cancer research

Sunday, September 17th, 2017

The annual Chic Awearness fundraising event that supports ovarian cancer research at major medical centers, including Vanderbilt University Medical Center (VUMC), will be held Monday, Sept. 25, 6:30 – 8:30 p.m., at Prima Restaurant, 700 12th Ave. South.

HDAC3 role in B-cell development

Monday, August 7th, 2017

Histone deacetylases (HDACs) are enzymes that modulate gene expression and have important roles in development and disease. HDAC inhibitors are active against lymphoma, and understanding the roles of specific HDACs is important for further therapeutic development. Scott Hiebert, Ph.D., and colleagues used a mouse model to explore the role of HDAC3 in the early development […]

PET imaging to predict tumor response

Thursday, June 15th, 2017

About 10 percent of patients with colorectal cancer express a mutated form of the signaling molecule BRAF, which may be targeted for treatment by selective BRAF inhibitors. PET (positron emission tomography) imaging using a standard glucose probe is not able to predict response to BRAF inhibitors. In addition to becoming dependent on glucose, cancer cells […]

Next Page »